# Ivarmacitinib for Refractory Behcet's Syndrome

> **NCT07634848** · PHASE2 · WITHDRAWN · sponsor: **Liu Tian**

## Conditions studied

- Behcet's Syndrome

## Interventions

- **DRUG:** Ivarmacitinib

## Key facts

- **NCT ID:** NCT07634848
- **Lead sponsor:** Liu Tian
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-06-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Plans to rejoin a center
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07634848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07634848, "Ivarmacitinib for Refractory Behcet's Syndrome". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07634848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*